Celling Biosciences is advancing the future of medicine through the innovation of point-of-care, autologous regenerative cell therapies.

Their dedicated team of scientists, engineers and physicians are focused on developing point-of-care systems, innovative surgical techniques and technology platforms that create the optimal environment for regenerative cell therapies to promote healing and the regeneration of tissue.

ABI completed a contract service agreement with Celling Biosciences at our ABI@TLCC lab in Georgetown, TX before joining our new Bioscience Incubator at ACC Highland Campus.  We are happy to have them join us as a member company.